[go: up one dir, main page]

CN1699562A - Method for separation and purification of gene recombinant protein heme oxygenase - Google Patents

Method for separation and purification of gene recombinant protein heme oxygenase Download PDF

Info

Publication number
CN1699562A
CN1699562A CN 200510026385 CN200510026385A CN1699562A CN 1699562 A CN1699562 A CN 1699562A CN 200510026385 CN200510026385 CN 200510026385 CN 200510026385 A CN200510026385 A CN 200510026385A CN 1699562 A CN1699562 A CN 1699562A
Authority
CN
China
Prior art keywords
heme oxygenase
recombinant protein
separation
purification
expanded bed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510026385
Other languages
Chinese (zh)
Other versions
CN1289666C (en
Inventor
胡洪波
张雪洪
彭华松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Jiao Tong University
Original Assignee
Shanghai Jiao Tong University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Jiao Tong University filed Critical Shanghai Jiao Tong University
Priority to CN 200510026385 priority Critical patent/CN1289666C/en
Publication of CN1699562A publication Critical patent/CN1699562A/en
Application granted granted Critical
Publication of CN1289666C publication Critical patent/CN1289666C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)

Abstract

The invention relates to a process for separation and purification of gene recombinant protein heme oxygenase, which comprises subjecting the expression recombination protoheme oxygenase-1 fermentation liquor to centrifugal collection of cells, ultrasonic wave fragmenting, expanded-bed ion exchange chromatography and gel filtration chromatography for purification preparation. Compared with the existing separation process, provided method has the advantages of substantially reduced time of separation process and increased yield of recombination human heme oxygenase-1.

Description

The method of the separation and purification of gene recombinant protein heme oxygenase
Technical field
What the present invention relates to is the method for a kind of preparation method's of technical field of bioengineering, particularly a kind of gene recombinant protein heme oxygenase separation and purification.
Background technology
Heme oxygenase (Heme Oxygenase, HO) be middle existence the in the mammalian body, oxydase with multiple function relevant with the heme metabolism, it makes the methyl bridge cracking on the protoheme tetrapyrrole ring, finally forms the uteroverdine and the CO of equivalent and discharges iron atom.The eighties in last century middle and advanced stage, Maines etc. take the lead in, and separation and purification obtains in tissue such as the liver of animal and human's body, spleen, lung, brain and testis.So far; obtain three kinds of HO isozyme: HO-1, HO-2 and HO-3 in human and Mammals, HO-1 is induction type HO, as a kind of stress protein; under the condition that some hostile environments stimulate and disease exists, can play the certain protection effect to body, tissue.HO-1 can play the protection transplant organ and reduce the injury that rejection brings in the organ transplantation process, showing good application prospects aspect the pedicterus treatment simultaneously.In general, in actual production, generally need steps such as cytoclasis, centrifugal settling, salt precipitation, anion-exchange chromatography, cation-exchange chromatography and gel permeation chromatography to obtaining highly purified heme oxygenase from lysis.Product yield that various separating step causes low (common product yield about 10%) and production cycle are long, become the bottleneck problem of whole process of production.Therefore, selecting fast and effectively, separation means is the key that addresses the above problem.In recent years, the proposition of integrated isolation technique notion is that bioseparation technology has been opened up new field, and becomes the new focus in the bioseparation technology research gradually, and the expanded bed adsorption technology is exactly one of them.Expanded bed is liquid-solid fluid bed that the solids fluidisation is in stable condition, the back-mixing degree is very little.The expanded bed adsorption technology can be from the coarse fodder liquid that contains cell and cell debris direct Separation and Recovery target product, and save steps such as centrifugal, filtration.
Find by prior art documents, have not yet to see relevant expanded bed technology and be used for the recombinate method of heme oxygenase-1 of separation and purification people.The expanded bed technology is applied to the purge process of recombinant human heme oxygenase-1, can replace the existing purge process that comprises based on centrifugal settling, salt precipitation, hydrophobic interaction chromatography, anion-exchange chromatography, cation-exchange chromatography and gel permeation chromatography, thereby shorten the purifying time greatly, improve the product activity yield, cut down the consumption of energy.
Summary of the invention
The objective of the invention is to overcome deficiency of the prior art, a kind of method of separation and purification of gene recombinant protein heme oxygenase is provided.Make that its method is simple, the cycle is short, the product activity recovery is high is the method for main means with expanded bed.
The present invention is achieved by the following technical solutions, and the present invention carries out the purifying preparation with the fermented liquid of express recombinant heme oxygenase-1 through centrifugal collecting cell, ultrasonic disruption, expanded bed ion exchange chromatography and gel permeation chromatography.
Comprise that step is as follows:
1. expanded bed ion exchange chromatography
With refrigerated centrifuge with the centrifugal 15min of fermented liquid, collecting cell, again suspend with damping fluid, with ultrasonic disruption instrument smudge cells, after cytoclasis liquid dilutes 2~6 times with damping fluid, the expansion column is earlier with Tris-HCl damping fluid balance, feed the fermented liquid that has diluted from the expanded bed bottom then, carry out adsorption operations, damping fluid cleans 1~5 column volume under the expanded bed state, remove foreign protein and cell debris solid substance, at the fixed bed operation state with containing 1mol/L NaCl buffer solution for gradient elution, collect active peak, wash-out finishes when the chromatographic peak response value reaches baseline position.
Step 1. in:
Described fermented liquid is centrifugal under 4 ℃ of conditions, and centrifugal speed is 4000rpm.
Described damping fluid is: 0.001~0.05mol/L pH7.0~9.0.
Described sodium phosphate salt damping fluid is at 20~30 ℃, feeds the fermented liquid that has diluted with the flow velocity of 100~300cm/h from the expanded bed bottom.
Described expanded bed is controlled its bed expansion ratio and is 1.5~3.0 and carries out adsorption operations.
Described damping fluid cleans under the expanded bed state with the flow velocity of 100~300cm/h.
2. gel permeation chromatography
Top elutriant is joined in the Sephacryl S-200 gel chromatography column, finish to going out the peak, collect active peak, preserve after the lyophilize with the phosphate buffered saline buffer washing.
Step 2. in:
Described elutriant adds with the flow velocity of 10~50cm/h.
Described phosphate buffered saline buffer, for: 0.001~0.05mol/L pH6.0~8.0.
Described phosphate buffered saline buffer finishes to going out the peak with the washing of the flow velocity of 10~50cm/h.
Purifying Heme Oxygenase-1's of the present invention process is compared with existing separation method, its tangible advantage is: after the somatic cells fragmentation, need not centrifugal at low temperatures, saltout, dissolution precipitation and the dissolving after centrifugal process, be directly used in the expanded bed adsorption chromatographic separation after can suitably diluting, shortened the time of sepn process greatly, improve the yield of recombinant human heme oxygenase-1 significantly, and reduced energy consumption.This technology has broad application prospects in the purge process of recombinant human heme oxygenase-1.
Embodiment
Below in conjunction with specific embodiment technical scheme of the present invention is elaborated
Embodiment 1
With refrigerated centrifuge with fermented liquid under 4 ℃ of conditions with the centrifugal 15min of the speed of 4000rpm, collecting cell suspends again with the Tris-HCl damping fluid of 0.005mol/L pH7.0, with ultrasonic disruption instrument smudge cells.Cytoclasis liquid dilutes 2 times with the Tris-HCl damping fluid of 0.005mol/L pH7.0.StreamlineDEAE is filled in XK 26 chromatographic columns, and packing height is 11cm.Fluid distributor on the chromatographic column is adjusted to the 22.5cm place, fixing.Feed the Tris-HCl damping fluid of 0.005mol/L pH7.0 from the chromatographic column bottom, make 2 times of bed expansions, balance 30min.With diluted stock liquid feed from the chromatographic column bottom, regulate the flow velocity of feed liquid, the ratio of expansion of keeping expanded bed is constant, collects simultaneously from the effusive solution of chromatographic column.Behind the last sample, keep rate of expansion constant, feed the Tris-HCl damping fluid of 0.005mol/L pH7.0, clean 2~3 column volumes, collect the effusive solution of wash phase chromatographic column.To go up fluid distributor and reduce to the 11.5cm place, adopt the fixed bed operation mode, flow velocity with 60cm/h carries out gradient elution from the Tris-HCl damping fluid that the feeding of chromatographic column top contains the 0.005mol/LpH7.0 of 1mol/L NaCl, collect active peak, wash-out finishes when the chromatographic peak response value reaches baseline position.
The flow velocity of top elutriant with 40cm/h joined in the Sephacryl S-200 gel chromatography column, finish to going out the peak with the flow velocity washing identical, collect active peak, preserve after the lyophilize with sample introduction with the phosphate buffered saline buffer of 0.02mol/L pH7.5.
Embodiment 2
With refrigerated centrifuge with fermented liquid under 4 ℃ of conditions with the centrifugal 15min of the speed of 4000rpm, collecting cell suspends again with the Tris-HCl damping fluid of 0.01mol/L pH8.0, with ultrasonic disruption instrument smudge cells.Cytoclasis liquid dilutes 3 times with the Tris-HCl damping fluid of 0.01mol/L pH8.0.StreamlineDEAE is filled in XK 26 chromatographic columns, and packing height is 11cm.Fluid distributor on the chromatographic column is adjusted to the 28cm place, fixing.Feed the Tris-HCl damping fluid of 0.01mol/L pH8.0 from the chromatographic column bottom, make 2.5 times of bed expansions, balance 30min.With diluted stock liquid feed from the chromatographic column bottom, regulate the flow velocity of feed liquid, the ratio of expansion of keeping expanded bed is constant, collects simultaneously from the effusive solution of chromatographic column.Behind the last sample, keep rate of expansion constant, feed the Tris-HCl damping fluid of 0.01mol/L pH8.0, clean 3~4 column volumes, collect the effusive solution of wash phase chromatographic column.To go up fluid distributor and reduce to the 11.5cm place, adopt the fixed bed operation mode, flow velocity with 60cm/h carries out gradient elution from the Tris-HCl damping fluid that the feeding of chromatographic column top contains the 0.01mol/LpH8.0 of 1mol/L NaCl, collect active peak, wash-out finishes when the chromatographic peak response value reaches baseline position.
The flow velocity of top elutriant with 20cm/h joined in the Sephacryl S-200 gel chromatography column, finish to going out the peak with the flow velocity washing identical, collect active peak, preserve after the lyophilize with sample introduction with the phosphate buffered saline buffer of 0.05mol/L pH7.0.
Embodiment 3
With refrigerated centrifuge with fermented liquid under 4 ℃ of conditions with the centrifugal 15min of the speed of 4000rpm, collecting cell suspends again with the Tris-HCl damping fluid of 0.02mol/L pH8.5, with ultrasonic disruption instrument smudge cells.Cytoclasis liquid dilutes 2 times with the Tris-HCl damping fluid of 0.02mol/L pH 8.5.StreamlineDEAE is filled in XK 26 chromatographic columns, and packing height is 11cm.Fluid distributor on the chromatographic column is adjusted to the 28cm place, fixing.Feed the Tris-HCl damping fluid of 0.02mol/L pH8.5 from the chromatographic column bottom, make 2.5 times of bed expansions, balance 30min.With diluted stock liquid feed from the chromatographic column bottom, regulate the flow velocity of feed liquid, the ratio of expansion of keeping expanded bed is constant, collects simultaneously from the effusive solution of chromatographic column.Behind the last sample, keep rate of expansion constant, feed the Tris-HCl damping fluid of 0.02mol/L pH8.5, clean 3~4 column volumes, collect the effusive solution of wash phase chromatographic column.To go up fluid distributor and reduce to the 11.5cm place, adopt the fixed bed operation mode, flow velocity with 60cm/h carries out gradient elution from the Tris-HCl damping fluid that the feeding of chromatographic column top contains the 0.02mol/LpH8.5 of 1mol/L NaCl, collect active peak, wash-out finishes when the chromatographic peak response value reaches baseline position.
The flow velocity of top elutriant with 40cm/h joined in the Sephacryl S-200 gel chromatography column, finish to going out the peak with the flow velocity washing identical, collect active peak, preserve after the lyophilize with sample introduction with the phosphate buffered saline buffer of 0.02mol/L pH7.5.

Claims (10)

1.一种基因重组蛋白血红素加氧酶的分离纯化的方法,其特征在于:将表达重组血红素加氧酶-1的发酵液,经离心收集细胞、超声波破碎、膨胀床离子交换层析和凝胶过滤层析进行纯化制备,冷冻干燥后保存。1. A method for the separation and purification of gene recombinant protein heme oxygenase, characterized in that: the fermentation broth expressing recombinant heme oxygenase-1 is centrifuged to collect cells, ultrasonic crushing, expanded bed ion exchange chromatography Purified and prepared by gel filtration chromatography, and stored after freeze-drying. 2.根据权利要求1所述的基因重组蛋白血红素加氧酶的分离纯化的方法,其特征是,包括步骤如下:2. the method for the separation and purification of gene recombinant protein heme oxygenase according to claim 1, is characterized in that, comprises steps as follows: ①膨胀床离子交换层析① Expanded bed ion exchange chromatography 用冷冻离心机将发酵液离心15min,收集细胞,用Tris-HCl缓冲液重新悬浮,用超声波破碎仪破碎细胞,细胞破碎液用Tris-HCl缓冲液稀释2~6倍后,膨胀床柱先用Tris-HCl缓冲液平衡,然后从膨胀床底部通入已稀释的发酵液,进行吸附操作,缓冲液在膨胀床状态下清洗1~5个柱体积,去除杂蛋白和细胞碎片固形物,在固定床操作状态用含1mol/L NaCl缓冲液梯度洗脱,收集活性峰,当色谱峰响应值达到基线位置时洗脱完毕;Centrifuge the fermentation broth with a refrigerated centrifuge for 15 minutes, collect the cells, resuspend them with Tris-HCl buffer, and break the cells with an ultrasonic breaker. -HCl buffer balance, and then pass the diluted fermentation broth from the bottom of the expanded bed for adsorption operation, the buffer solution is washed in the expanded bed state for 1 to 5 column volumes to remove impurity proteins and cell debris solids, and in the fixed bed In the operating state, use gradient elution with a buffer containing 1mol/L NaCl, collect the active peak, and complete the elution when the response value of the chromatographic peak reaches the baseline position; ②凝胶过滤层析②Gel filtration chromatography 将上面的洗脱液加入到凝胶层析柱中,用磷酸盐缓冲液洗涤至出峰完毕,收集活性峰。The above eluate was added to the gel chromatography column, washed with phosphate buffer until the peak was eluted, and the active peak was collected. 3.根据权利要求2所述的基因重组蛋白血红素加氧酶的分离纯化的方法,其特征是,在步骤①中:所述的发酵液于4℃条件下离心,离心速度为4000rpm。3. The method for separating and purifying gene recombinant protein heme oxygenase according to claim 2, characterized in that, in step ①, the fermentation broth is centrifuged at 4°C at a centrifugation speed of 4000rpm. 4.根据权利要求2所述的基因重组蛋白血红素加氧酶的分离纯化的制备方法,其特征是,在步骤①中:所述的缓冲液为:0.001~0.05mol/L pH7.0~9.0。4. The preparation method for the separation and purification of gene recombinant protein heme oxygenase according to claim 2, characterized in that, in step ①: the buffer is: 0.001~0.05mol/L pH7.0~ 9.0. 5.根据权利要求2所述的基因重组蛋白血红素加氧酶的分离纯化的方法,其特征是,在步骤①中:所述的磷酸盐缓冲液在20~30℃,以100~300cm/h的流速从膨胀床底部通入已稀释的发酵液。5. The method for separating and purifying gene recombinant protein heme oxygenase according to claim 2, characterized in that, in step ①, the phosphate buffer solution is heated at 20-30°C at 100-300cm/ The flow rate of h is passed into the diluted fermentation broth from the bottom of the expanded bed. 6.根据权利要求2所述的基因重组蛋白血红素加氧酶的分离纯化的方法,其特征是,在步骤①中:所述的膨胀床,控制其床层膨胀比为1.5~3.0进行吸附操作。6. The method for separating and purifying gene recombinant protein heme oxygenase according to claim 2, characterized in that, in step ①, the expanded bed is controlled to have a bed expansion ratio of 1.5 to 3.0 for adsorption operate. 7.根据权利要求2所述的基因重组蛋白血红素加氧酶的分离纯化的方法,其特征是,在步骤①中:所述的缓冲液,以100~300cm/h的流速在膨胀床状态下清洗。7. The method for the separation and purification of genetically recombinant protein heme oxygenase according to claim 2, characterized in that, in step 1.: the buffer solution is in an expanded bed state at a flow rate of 100 to 300 cm/h down to wash. 8.根据权利要求2所述的基因重组蛋白血红素加氧酶的分离纯化的方法,其特征是,在步骤②中:所述的洗脱液以10~50cm/h的流速加入。8. The method for separating and purifying the gene recombinant protein heme oxygenase according to claim 2, characterized in that, in step ②: the eluent is added at a flow rate of 10-50 cm/h. 9.根据权利要求2所述的基因重组蛋白血红素加氧酶的分离纯化的方法,其特征是,在步骤②中:所述的磷酸盐缓冲液,为:0.001~0.05mol/LpH6.0~8.0。9. The method for separating and purifying the genetically recombinant protein heme oxygenase according to claim 2, characterized in that, in step ②: the phosphate buffer is: 0.001~0.05mol/LpH6.0 ~8.0. 10.根据权利要求2所述的的基因重组蛋白血红素加氧酶的分离纯化的制备方法,其特征是,在步骤②中:所述的磷酸盐缓冲液,以10~50cm/h的流速洗涤至出峰完毕。10. The preparation method for the separation and purification of genetically recombinant protein heme oxygenase according to claim 2, characterized in that, in step ②, the phosphate buffer solution is used at a flow rate of 10-50 cm/h Wash until peak elution is complete.
CN 200510026385 2005-06-02 2005-06-02 Process for separation and purification of gene recombinant protein heme oxygenase Expired - Fee Related CN1289666C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510026385 CN1289666C (en) 2005-06-02 2005-06-02 Process for separation and purification of gene recombinant protein heme oxygenase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510026385 CN1289666C (en) 2005-06-02 2005-06-02 Process for separation and purification of gene recombinant protein heme oxygenase

Publications (2)

Publication Number Publication Date
CN1699562A true CN1699562A (en) 2005-11-23
CN1289666C CN1289666C (en) 2006-12-13

Family

ID=35475809

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510026385 Expired - Fee Related CN1289666C (en) 2005-06-02 2005-06-02 Process for separation and purification of gene recombinant protein heme oxygenase

Country Status (1)

Country Link
CN (1) CN1289666C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101870981A (en) * 2010-05-28 2010-10-27 中国人民解放军军事医学科学院野战输血研究所 Expression and purification method of heme oxygenase-1, and epitopes thereof
CN105727379A (en) * 2016-02-25 2016-07-06 顾宇春 Haem oxygenase drug eluting stent
CN107937420A (en) * 2017-12-20 2018-04-20 陈如凯 The HMOX1 mutators and its application that 127th site is undergone mutation
CN107937421A (en) * 2017-12-20 2018-04-20 陈如凯 The HMOX1 mutators and its application that 111st site is undergone mutation

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101870981A (en) * 2010-05-28 2010-10-27 中国人民解放军军事医学科学院野战输血研究所 Expression and purification method of heme oxygenase-1, and epitopes thereof
CN105727379A (en) * 2016-02-25 2016-07-06 顾宇春 Haem oxygenase drug eluting stent
CN107937420A (en) * 2017-12-20 2018-04-20 陈如凯 The HMOX1 mutators and its application that 127th site is undergone mutation
CN107937421A (en) * 2017-12-20 2018-04-20 陈如凯 The HMOX1 mutators and its application that 111st site is undergone mutation

Also Published As

Publication number Publication date
CN1289666C (en) 2006-12-13

Similar Documents

Publication Publication Date Title
CN104774182B (en) The extraction of erythrothioneine and purification process
CN101638427B (en) A kind of purification method of virus antigen
TWI748411B (en) Method of purifying botulinum toxin
CN102329381A (en) Method for simultaneously separating high-purity phycocyanin and allophycocyanin and application thereof
Li et al. Enzyme-assisted extraction of naphthodianthrones from Hypericum perforatum L. by 12C6+-ion beam-improved cellulases
TWI797442B (en) Method of purifying botulinum toxin
CN1699562A (en) Method for separation and purification of gene recombinant protein heme oxygenase
CN110951814B (en) Method for preparing prostaglandin E1 using genetically engineered cyclooxygenase-1 and genetically engineered prostaglandin E synthase-1
KR910008643B1 (en) Method for Purifying Hepatitis B Virus Surface Antigen (HBs Antigen)
CN101367865B (en) Production process for high purity porcine blood albumin and uses thereof
CN107033237A (en) A kind of Human Plasma Apolipoprotein A I isolation and purification method
CN115948351B (en) Method for separating and purifying CVB1
CN103694367B (en) A kind of extraction and application method with anti-oxidant activity clam polysaccharide
CN102924586A (en) Method for producing pregnant mare serum gonactotropin by monoclonal antibody technology
EP4299580A1 (en) High-yield purification method for target protein
CN103102252B (en) A method for separating and purifying (+)-isolaricoresinol and (-)-larixin from Folium chinensis
CN110468172A (en) A kind of method and kit isolating and purifying recombination LEA protein
CN107446905B (en) Method for purifying recombinant human lysozyme
CN102321150B (en) A method for isolating recombinant human antibody from mammary gland bioreactor expression product
CN114591926A (en) Purification method of human respiratory chain compound I
CN1563400A (en) Method for separating and preparing prodigiosin
CN103044510B (en) The isolation technique of ergosterol in Phellinus bacterium
CN107418945B (en) A method for separating and purifying Fusarium thaliana to obtain β-glucosidase
RU2434018C2 (en) Method of obtaining and purifying human inhibin-a
CN102516381B (en) Natural sex storage protein-2 as well as preparation and use for same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20061213